Patent · US Active

Wet granulation using a water sequestering agent

US8652492B2 · kind B2 · utility

0Cited by

9References

9Claims

0Family size

Assignee

Rigel Pharmaceuticals, Inc. · US

Inventors

Thomas Sun · Fremont, US
Ray J. Lo · San Leandro, US

Key dates

Filing date	Jan 10, 2013
Grant date	Feb 18, 2014
Priority date	—
Expiry date	Jan 10, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate disodium salt (Compound 1) prepared by a wet granulation process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.